TissGeneSummary for SLC6A13 |
Gene summary |
Basic gene information | Gene symbol | SLC6A13 |
Gene name | solute carrier family 6 (neurotransmitter transporter), member 13 | |
Synonyms | GAT-2|GAT2|GAT3 | |
Cytomap | UCSC genome browser: 12p13.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001190997.2, NM_001243392.1,NM_016615.4, | |
Description | GABA transport proteinGABA transporter 2sodium- and chloride-dependent GABA transporter 2solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | |
Modification date | 20141211 | |
dbXrefs | MIM : 615097 | |
HGNC : HGNC | ||
Ensembl : ENSG00000010379 | ||
HPRD : 10239 | ||
Vega : OTTHUMG00000168053 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_SLC6A13 | |
BioGPS: 6540 | ||
Pathway | NCI Pathway Interaction Database: SLC6A13 | |
KEGG: SLC6A13 | ||
REACTOME: SLC6A13 | ||
Pathway Commons: SLC6A13 | ||
Context | iHOP: SLC6A13 | |
ligand binding site mutation search in PubMed: SLC6A13 | ||
UCL Cancer Institute: SLC6A13 | ||
Assigned class in TissGDB* | B | |
Included tissue-specific gene expression resources | HPA,TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Kidney | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICH | |
Reference showing the relevant tissue of SLC6A13 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for SLC6A13 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
LUAD | -2.660399659 | 0.65094172 | -3.311341379 | 2.48E-36 | 9.27E-34 |
LUSC | -2.332362945 | 0.754315486 | -3.086678431 | 2.05E-28 | 7.10E-27 |
LIHC | 2.239675996 | 4.104741996 | -1.865066 | 3.98E-07 | 2.38E-06 |
KICH | -1.314926004 | 5.413489996 | -6.728416 | 1.49E-19 | 1.01E-17 |
KIRP | 5.275243121 | 6.570396246 | -1.295153125 | 0.0164 | 0.034108349 |
KIRC | 7.051464996 | 5.990126107 | 1.061338889 | 0.000322 | 0.000641995 |
Top |
TissGene-miRNA for SLC6A13 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for SLC6A13 |
TissGeneSNV for SLC6A13 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.G261E | SKCM | 3 |
p.R251* | SKCM | 2 |
p.P59S | SKCM | 2 |
p.G169E | SKCM | 2 |
p.P241S | SKCM | 2 |
p.M280I | SKCM | 2 |
p.S197F | SKCM | 2 |
p.R159X | SKCM | 2 |
p.S289F | SKCM | 2 |
p.R411H | DLBC | 1 |
p.T590N | LUAD | 1 |
p.G202A | LUAD | 1 |
p.R475H | UCEC | 1 |
p.G431R | SKCM | 1 |
p.P16S | PRAD | 1 |
p.A238T | SKCM | 1 |
p.P588L | SKCM | 1 |
p.Q94P | SARC | 1 |
p.V459L | HNSC | 1 |
p.G95E | SKCM | 1 |
p.Y303* | SKCM | 1 |
p.A316T | UCEC | 1 |
p.E177K | KIRP | 1 |
p.F380V | CESC | 1 |
p.E48K | SKCM | 1 |
p.Y406F | LIHC | 1 |
p.G67R | ESCA | 1 |
p.L243F | SKCM | 1 |
p.D147N | SKCM | 1 |
p.P97A | PAAD | 1 |
p.G337C | LUAD | 1 |
p.F86I | BRCA | 1 |
p.G82S | SKCM | 1 |
p.G170S | LUAD | 1 |
p.R272C | STAD | 1 |
p.V367L | LUAD | 1 |
p.L435F | LUAD | 1 |
p.G174S | SKCM | 1 |
p.A136T | BLCA | 1 |
p.S171C | LUSC | 1 |
p.L518M | ESCA | 1 |
p.R71I | UCEC | 1 |
p.E89X | SKCM | 1 |
p.W224S | KIRP | 1 |
p.D404N | HNSC | 1 |
p.L116M | COAD | 1 |
p.P496L | SKCM | 1 |
p.S322G | KIRC | 1 |
p.G439E | LUAD | 1 |
p.S171F | SKCM | 1 |
p.N321S | READ | 1 |
p.I360T | STAD | 1 |
p.A291T | STAD | 1 |
p.P315S | SKCM | 1 |
p.V55I | UCEC | 1 |
p.S427C | SKCM | 1 |
p.G7D | UCEC | 1 |
p.V76I | SARC | 1 |
p.L421F | SKCM | 1 |
p.G67E | SKCM | 1 |
p.G581R | UCEC | 1 |
p.E481K | STAD | 1 |
p.T271M | CESC | 1 |
p.R565H | SKCM | 1 |
p.L336P | KIRP | 1 |
p.R323Q | COAD | 1 |
p.R383H | COAD | 1 |
p.P407S | SKCM | 1 |
p.K24E | KIRP | 1 |
p.P268R | LUAD | 1 |
p.P176S | SKCM | 1 |
p.A584S | LUSC | 1 |
p.T254R | LUSC | 1 |
p.M188I | SKCM | 1 |
p.D2N | SKCM | 1 |
p.A586T | PAAD | 1 |
p.L329F | SKCM | 1 |
p.R189Q | LUAD | 1 |
p.R272C | SKCM | 1 |
p.S335C | SKCM | 1 |
p.A361T | PRAD | 1 |
p.R189Q | BRCA | 1 |
p.R190W | PRAD | 1 |
p.H408N | LUAD | 1 |
p.P268S | SKCM | 1 |
p.G339R | SKCM | 1 |
p.L432P | ESCA | 1 |
p.E389K | COAD | 1 |
p.F326C | LIHC | 1 |
p.P149S | SKCM | 1 |
p.L266M | STAD | 1 |
p.R565H | HNSC | 1 |
p.P256L | SKCM | 1 |
p.K106R | LIHC | 1 |
p.F70L | ESCA | 1 |
p.P59L | SKCM | 1 |
p.K23Q | UCEC | 1 |
p.Y211X | SKCM | 1 |
p.A401V | DLBC | 1 |
p.S600T | LGG | 1 |
p.G33E | ESCA | 1 |
p.M39I | UCEC | 1 |
p.R411C | STAD | 1 |
p.H408Y | HNSC | 1 |
p.M339I | LUSC | 1 |
p.P90S | SKCM | 1 |
p.W35* | UCEC | 1 |
p.P490S | BLCA | 1 |
p.P268Q | KIRC | 1 |
p.G257E | SKCM | 1 |
p.L87F | BRCA | 1 |
p.E25K | SKCM | 1 |
p.A190T | COAD | 1 |
p.S3R | LUAD | 1 |
p.L357P | LIHC | 1 |
p.R364Q | GBM | 1 |
p.K305R | KIRC | 1 |
p.L402Q | LUAD | 1 |
p.L204Q | KIRP | 1 |
p.P407L | GBM | 1 |
p.R190W | LGG | 1 |
p.P182S | SKCM | 1 |
p.R411H | STAD | 1 |
p.A376V | UCEC | 1 |
p.V127I | COAD | 1 |
p.E89* | SKCM | 1 |
Top |
TissGeneCNV for SLC6A13 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for SLC6A13 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for SLC6A13 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for SLC6A13 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for SLC6A13 |
TissGeneDrug for SLC6A13 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for SLC6A13 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0004936 | Mental disorders | 1 | GAD |
umls:C0014544 | Epilepsy | 1 | BeFree |
umls:C0020503 | Hyperparathyroidism, Secondary | 1 | GAD |
umls:C0022661 | Kidney Failure, Chronic | 1 | GAD |
umls:C0036341 | Schizophrenia | 1 | BeFree |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |
umls:C1561535 | Creatinine finding | 1 | GAD |
umls:C1561643 | Chronic Kidney Diseases | 1 | GWASCAT |